Dr. Agarwal's Health Care IPO GMP History
Dr. Agarwal's Health Care IPO has been listed on February 4, 2025 at a listing price of ₹402, against the issue price of ₹402 — a gain of ₹0 (+0%). The GMP peaked at ₹140 on 23 January 2025 and reached a low of ₹0 on 3 February 2025. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Dr. Agarwal's Health Care IPO raised ₹3027.26 Cr. through its IPO at a price band of ₹382 to ₹402 per share, with a lot size of 35 shares. The IPO was open for subscription from 29 Jan 2025 to 31 Jan 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 10 Nov, 5:58 AM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 03 Feb 2025 | ₹ 0 | ▼ | -- | — | — |
| 31 Jan 2025 | ₹ 1 | ▼ | -- | — | — |
| 30 Jan 2025 | ₹ 2 | ▼ | -- | — | — |
| 29 Jan 2025 | ₹ 8 | ▼ | 2% | — | — |
| 27 Jan 2025 | ₹ 16 | ▼ | 4% | — | — |
| 25 Jan 2025 | ₹ 40 | ▼ | 10% | — | — |
| 24 Jan 2025 | ₹ 65 | ▼ | 16% | — | — |
| 23 Jan 2025 | ₹ 140 | — | 35% | — | — |
Dr. Agarwal's Health Care IPO dates
Key dates from opening to listing. Today is 10 November.
- Open 29 Jan 2025
- Close 31 Jan 2025
- Allotment 03 Feb 2025
- Refund/credit 04 Feb 2025
- Listing 04 Feb 2025
Dr. Agarwal's Health Care IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹402 |
|---|---|
| Listing gain / loss | +₹0 per share |
| Listing date | 04 Feb, 2025 |
| Actual listing price | ₹402 (+0%) |
Is Dr. Agarwal's Health Care IPO GMP reliable?
Grey market premium for Dr. Agarwal's Health Care IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Dr. Agarwal's Health Care IPO full review for a fundamentals-based assessment before making any grey market trades.
Dr. Agarwal's Health Care IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Dr. Agarwal's Health Care IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Dr. Agarwal's Health Care IPO
Dr. Agarwal's Health Care Limited provides eye care services. The offering covers cataract, refractive and other surgeries, consultations and diagnoses. On 30 September 2024 it had 209 facilities, of which 193 were in India and 16 were across nine countries in Africa.
The company uses a hub-and-spoke model, which lets larger centres support smaller ones. Growth has come from new centres and from acquisitions.
The promoters include doctors from the Agarwal family and family trusts. Dr. Amar Agarwal and Dr. Athiya Agarwal are among the named promoters.
The IPO was Rs 3,027.26 crore. Only Rs 300.00 crore was fresh issue and Rs 2,727.26 crore was offer for sale. Rs 195.00 crore of the proceeds was planned for repaying borrowings.
Frequently asked
What is the GMP of Dr. Agarwal's Health Care IPO?
The current Grey Market Premium (GMP) of Dr. Agarwal's Health Care IPO is not yet started or active in the market.
What is the Kostak Price of Dr. Agarwal's Health Care IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Dr. Agarwal's Health Care IPO is not available.
What is the Subject to Sauda Price of Dr. Agarwal's Health Care IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Dr. Agarwal's Health Care IPO?
Dr. Agarwal's Health Care IPO listed on February 4, 2025 at ₹402, against the issue price of ₹402 — a gain of +0%.
How did the GMP of Dr. Agarwal's Health Care IPO trend before listing?
The GMP of Dr. Agarwal's Health Care IPO was falling in its final days before listing. The GMP peaked at ₹140 on 23 January 2025. View the day-wise table above for the complete GMP history.
Explore Dr. Agarwal's Health Care IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
